103 results
Page 5 of 6
424B5
gggbh0txa8bw87
8 Apr 19
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
cvk8hwsm ia
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
424B5
oa26 hetds9g
4 Apr 19
Prospectus supplement for primary offering
4:15pm
424B5
6pmu5q ho
4 Apr 19
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
eketm9mkgh6 qvtol
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.2
mnfst5xu
7 Jan 19
Regulation FD Disclosure
6:30am
8-K
EX-99.1
94q33kl2z7gijxbant
3 Dec 18
Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
8:07am
8-K
EX-99.2
cp8p8qmifv499on x3
15 Nov 18
Regulation FD Disclosure
4:03pm
8-K
EX-99.1
bto4i9e6w6i5
15 Nov 18
Regulation FD Disclosure
4:03pm